- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00732719
Compression Device Safety Study on Edema
October 29, 2008 updated by: ConvaTec Inc.
A Phase II Non-Comparative Study Evaluating the Effects of the Compression Test Device on Oedema
To evaluate the safety of the prototype Compression Device in subjects with Oedema
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Freiburg, Germany
- Hautarzt Phlebologe Allergologe
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects aged between 18 and 80, willing and able to provide written informed consent, and able to wear the device and follow the requirements of the protocol
- Subjects who have an ankle to brachial pressure index (ABPI) of at least 0.8.
- Subjects who suffer from chronic oedema (i.e. CEAP classification of C3, C4 or C5 1.)
- Subjects who have Chronic Venous Insufficiency (CVI), which has been present for 6 weeks or longer and who have refluxes >0.5 sec in one or more major venous segments, superficial or deep or both (CEAP classification: C3-C5 1.; Ep,s; As,d; Pr).
Exclusion Criteria:
- Subjects with a history of skin sensitivity to any of the components of the study product.
- Subjects who have previously been entered into the study before
- Subjects who have a history of Deep Vein Thrombosis (DVT) within the last 6 months
- Subjects who have an active leg ulcer (i.e. CEAP classification of C6 1).
- Subjects with active cardiac disease or significant history of cardiac disease (including history of myocardial infarction, heart failure, valvular disease, arrhythmia and those with a pacemaker or have previously had a pacemaker).
- Subjects who have initiated treatment or changed the dose within the past month of pharmaceutical agents that reduce clotting e.g. aspirin (except low-dose aspirin), anti-platelets, anti-coagulants and coumarin.
- Subjects who are currently taking pharmaceutical agents that can modify the amount of leg oedema (e.g., diuretics, dihydropyridine calcium channel blockers, phlebotonic drugs, or fluctuating doses of systemic steroids) or have taken these agents within the last 10 days.
- Subjects who are pregnant
- Subjects who have worn compression therapy in the last 48 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Profile A
Device worn; no pressure given (placebo)
|
|
ACTIVE_COMPARATOR: Profile B
Foot at 30mm Hg, Gaiter at 40 mm Hg, mid-calf at 30 mm Hg and upper cuff at 20mm Hg
|
|
ACTIVE_COMPARATOR: Profile C
Foot at 20mm Hg, Gaiter at 30 mm Hg, mid-calf at 20 mm Hg and upper cuff at 10mm Hg
|
|
ACTIVE_COMPARATOR: Profile D
Foot at 10mm Hg, Gaiter at 20 mm Hg, mid-calf at 10 mm Hg and upper cuff at 0mm Hg
|
|
ACTIVE_COMPARATOR: Profile E
Foot at 30mm Hg, Gaiter at 40 mm Hg, mid-calf at 40 mm Hg and upper cuff at 40mm Hg
|
|
ACTIVE_COMPARATOR: Profile F
Foot at 20mm Hg, Gaiter at 30 mm Hg, mid-calf at 30 mm Hg and upper cuff at 30mm Hg
|
|
ACTIVE_COMPARATOR: Profile G
Foot at 10mm Hg, Gaiter at 20 mm Hg, mid-calf at 20 mm Hg and upper cuff at 20mm Hg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
The nature and incidence of adverse events
|
Volume reduction
|
Oedema reduction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Wolfgang Vanscheidt, Hautarzt Phlebologe Allergologe
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2004
Primary Completion (ACTUAL)
November 1, 2004
Study Completion (ACTUAL)
December 1, 2004
Study Registration Dates
First Submitted
July 23, 2008
First Submitted That Met QC Criteria
August 11, 2008
First Posted (ESTIMATE)
August 12, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
October 31, 2008
Last Update Submitted That Met QC Criteria
October 29, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CW-0500-04-U332
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edema
-
Eye-yon MedicalCompletedCORNEAL EDEMAIsrael, Poland
-
Federico II UniversityCompletedPseudophakic Cystoid Macular Edema
-
California Retina ConsultantsRegeneron PharmaceuticalsCompletedDiabetic Macular Edema | Cystoid Macular EdemaUnited States
-
Postgraduate Institute of Medical Education and...CompletedDiabetic Macular Edema | Vision Disorders | Macular Edema, Cystoid | Clinically Significant Macular EdemaIndia
-
National Cardiovascular Center Harapan Kita Hospital...CompletedMyocardial Edema
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
Ellianne M. NasserRecruitingBone Marrow EdemaUnited States
-
OculisICON plcRecruitingDiabetic Macular EdemaUnited States
-
Novartis PharmaceuticalsNot yet recruiting
Clinical Trials on Prototype device (unnamed) worn-no pressure given (placebo) from inflatable cuffs
-
ConvaTec Inc.Bristol-Myers SquibbCompleted